-
CD161
- names:
CD161
- CAS号:
1627716-22-6
MDL Number: - MF(分子式): C26H21N5O2 MW(分子量): 435.48
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM002940-250mg | 250mg | ¥ 0.00 | ¥ 0.00 | Backorder | ¥ 0.00 | |||
| YZM002940-100mg | 100mg | >97% | ¥ 0.00 | ¥ 0.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | |
| CAS号 | 1627716-22-6 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C26H21N5O2 |
| 分子量 Molecular Weight | 435.48 |
| 溶解度Solubility | |
| 性状 | |
| 储藏条件 Storage conditions | 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description. |
CD161(CAS:1627716-22-6)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
| 产品说明 | CD161 (NKR-P1A) 是一种有效的,选择性的且口服生物可利用的溴结构域和末端 (BET) 溴结构域抑制剂,对 BRD4 BD1 和 BRD4 BD2 的IC50值 分别为 28.2 nM 和 7.2 nM |
| Introduction | CD161 (NKR1A) is a potent, selective and orally bioavailablebromodomain and extraerminal (BET) bromodomaininhibitor with anIC50s of 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2, respectively. CD161 has good anticancer activity. |
| Application1 | |
| Application2 | |
| Application3 |
CD161 (NKR-P1A) 是一种有效的,选择性的且口服生物可利用的溴结构域和末端 (BET) 溴结构域抑制剂,对 BRD4 BD1 和 BRD4 BD2 的IC50值 分别为 28.2 nM 和 7.2 nM。CD161 具有抗肿瘤活性。CD161 (NKR-P1A) is a potent, selective and orally bioavailablebromodomain and extra-terminal (BET) bromodomaininhibitor with anIC50s of 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2, respectively. CD161 has good anticancer activity[1].
【1】.Zhao Y, et al. Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. J Med Chem. 2017 May 11;60(9):3887-3901.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


